A detailed history of Alpine Peaks Capital, LP transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Alpine Peaks Capital, LP holds 28,509 shares of MEDP stock, worth $10.3 Million. This represents 5.97% of its overall portfolio holdings.

Number of Shares
28,509
Previous 27,159 4.97%
Holding current value
$10.3 Million
Previous $11.2 Million 15.0%
% of portfolio
5.97%
Previous 7.17%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$320.58 - $457.29 $432,783 - $617,341
1,350 Added 4.97%
28,509 $9.51 Million
Q2 2024

Aug 13, 2024

SELL
$372.0 - $424.34 $372,000 - $424,340
-1,000 Reduced 3.55%
27,159 $11.2 Million
Q1 2024

May 15, 2024

SELL
$284.87 - $413.31 $3.35 Million - $4.86 Million
-11,770 Reduced 29.48%
28,159 $11.4 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $420,912 - $578,458
1,850 Added 4.86%
39,929 $12.2 Million
Q3 2023

Nov 14, 2023

BUY
$233.98 - $281.67 $321,722 - $387,296
1,375 Added 3.75%
38,079 $9.22 Million
Q1 2023

May 12, 2023

BUY
$174.31 - $239.52 $654,185 - $898,918
3,753 Added 11.39%
36,704 $6.9 Million
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $1.08 Million - $1.6 Million
7,045 Added 27.19%
32,951 $7 Million
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $1.84 Million - $2.31 Million
12,680 Added 48.95%
38,586 $6.07 Million
Q2 2022

Aug 12, 2022

BUY
$130.2 - $168.03 $299,460 - $386,469
2,300 Added 9.74%
25,906 $3.88 Million
Q1 2022

May 16, 2022

BUY
$138.87 - $214.31 $930,429 - $1.44 Million
6,700 Added 39.63%
23,606 $3.86 Million
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $3.09 Million - $3.85 Million
16,906 New
16,906 $3.68 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $11.3B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Alpine Peaks Capital, LP Portfolio

Follow Alpine Peaks Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Peaks Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Peaks Capital, LP with notifications on news.